Abstract
Computed tomography lung cancer screening reduces lung cancer mortality. However, screening is underutilized. This study assesses the extent to which providers discuss lung cancer screening with their patients, as a lack of discussion and counseling may serve as a potential cause of low utilization rates. Data from 1667 adults aged 55–80 years sampled in the 2017 Health Information National Trends Survey was utilized. A weighted multivariable logistic regression model was fit with past-year discussion about lung cancer screening with a provider as the outcome. The adjusted odds of discussion were higher for current cigarette smokers compared to non-cigarette smokers (adjusted odds ratio = 3.91; 95% confidence interval [CI], 1.75 to 8.74). Despite higher odds, the absolute prevalence was low with only 18% (95% CI, 11.8 to 24.2%) of current adult smokers reporting a past-year discussion. Knowledge of screening from trusted sources of medical information, such as doctors, can increase screening rates and may ultimately reduce lung cancer mortality.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409. doi:https://doi.org/10.1056/NEJMoa1102873
Soneji S, Yang J, Tanner NT, Dang R, Silvestri GA, Black W (2017) Underuse of chest radiography versus computed tomography for lung cancer screening. Am J Public Health 107(8):1248–1250. https://doi.org/10.2105/AJPH.2017.303919
Jemal A, Fedewa SA (February 2017) Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015. JAMA Oncol 3:1278–1281. https://doi.org/10.1001/jamaoncol.2016.6416
Kanodra NM, Pope C, Halbert CH, Silvestri GA, Rice LJ, Tanner NT (2016) Primary care provider and patient perspectives on lung cancer screening. A qualitative study. Ann Am Thorac Soc 13(11):1977–1982. https://doi.org/10.1513/AnnalsATS.201604-286OC
Wiener RS, Koppelman E, Bolton R, Lasser KE, Borrelli B, Au DH, Slatore CG, Clark JA, Kathuria H (2018) Patient and clinician perspectives on shared decision-making in early adopting lung cancer screening programs: a qualitative study. J Gen Intern Med 33(7):1035–1042. https://doi.org/10.1007/s11606-018-4350-9
Stacey D, Bennett CL, Barry MJ et al (2011) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (10):CD001431. https://doi.org/10.1002/14651858.CD001431.pub3
Stacey D, Légaré F, Lewis KB (2017) Patient decision aids to engage adults in treatment or screening decisions. JAMA 318(7):657–658. https://doi.org/10.1001/jama.2017.10289
Bieber C, Nicolai J, Hartmann M, Blumenstiel K, Ringel N, Schneider A, Härter M, Eich W, Loh A (2009) Training physicians in shared decision-making-who can be reached and what is achieved? Patient Educ Couns 77(1):48–54. https://doi.org/10.1016/j.pec.2009.03.019
Hansberry DR, White MD, D’Angelo M et al (2018) Lung cancer screening guidelines: how readable are internet-based patient education resources? AJR Am J Roentgenol 211(1):W42–W46. https://doi.org/10.2214/AJR.17.19042
Pinsky PF, Zhu CS, Kramer BS. Lung cancer risk by years since quitting in 30+ pack year smokers. J Med Screen 2015;22(3):151–157. doi:https://doi.org/10.1177/0969141315579119
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 66 kb)
Rights and permissions
About this article
Cite this article
Soneji, S., Yang, J., Tanner, N.T. et al. Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Canc Educ 35, 678–681 (2020). https://doi.org/10.1007/s13187-019-01510-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-019-01510-9